Latest News and Events
Filter by
Selections
September 8, 2020
Arrowhead Pharmaceuticals to Participate in Upcoming September 2020 Conferences
Read MoreAugust 31, 2020
Arrowhead Presents Positive New Phase 1/2 Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at European Society of Cardiology Congress 2020
Read MoreAugust 28, 2020
Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data on Investigational Hepatitis B Therapeutic JNJ-3989 at The Digital Liver Congress
Read MoreAugust 18, 2020
Arrowhead Pharmaceuticals to Participate in Upcoming August 2020 Conferences
Read MoreAugust 18, 2020
Arrowhead Pharmaceuticals Initiates Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma
Read MoreAugust 11, 2020
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
Read MoreJuly 29, 2020